ResMed RMD Sleep And Breathing Health — Intangible Amortization
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's sleep and breathing health — intangible amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ResMed's sleep and breathing health — intangible amortization?
- ResMed (RMD) reported sleep and breathing health — intangible amortization of $1.42M in Q1 2026.
- How has ResMed's sleep and breathing health — intangible amortization changed year-over-year?
- ResMed's sleep and breathing health — intangible amortization increased by 20.2% year-over-year, from $1.18M to $1.42M.
- What is the long-term trend for ResMed's sleep and breathing health — intangible amortization?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — intangible amortization has grown at a 11.6% compound annual growth rate (CAGR), from $5.34M to $6.65M.
- What does sleep and breathing health — intangible amortization mean?
- This metric tracks the periodic non-cash expense related to the systematic write-down of intangible assets specifically associated with the Sleep and Breathing Health segment. These assets typically include acquired patents, intellectual property, and customer relationships resulting from past business acquisitions. It provides insight into the historical investment in inorganic growth and the ongoing impact of these acquisitions on the segment's reported profitability.